(Q34557491)

3 August 2017

1 reference

title

Multiple endocrine neoplasia type 2. (English)

1 reference

multiple endocrine neoplasia

3 August 2017

1 reference

1

Mariola Peczkowska

1 reference

3 August 2017

2

Andrzej Januszewicz

1 reference

3 August 2017

1 January 2005

1 reference

3 August 2017

1 reference

3 August 2017

4

1 reference

3 August 2017

1

1 reference

3 August 2017

25-36

1 reference

https://scigraph.springernature.com/pub.10.1007/s10689-005-0656-y

3 August 2017

0 references

cites work

Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10689-005-0656-Y

6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10689-005-0656-Y

A novel Val648Ile substitution in RET protooncogene observed in a Cys634Arg multiple endocrine neoplasia type 2A kindred presenting with an adrenocorticotropin-producing pheochromocytoma

21 January 2018

1 reference

12 December 2020

Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases

1 reference

12 December 2020

Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease

1 reference

12 December 2020

Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation

1 reference

12 December 2020

Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine.

1 reference

12 December 2020

Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential?

1 reference

12 December 2020

A Novel Germ-Line Point Mutation in RET Exon 8 (Gly533Cys) in a Large Kindred with Familial Medullary Thyroid Carcinoma

1 reference

12 December 2020

RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer

1 reference

12 December 2020

A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines

1 reference

12 December 2020

Surgical strategy for the treatment of medullary thyroid carcinoma

1 reference

12 December 2020

Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center

1 reference

12 December 2020

Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium

1 reference

12 December 2020

Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918

1 reference

12 December 2020

Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers

1 reference

12 December 2020

Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary

1 reference

12 December 2020

Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease

1 reference

12 December 2020

A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma

1 reference

12 December 2020

Direct, non-radioactive detection of mutations in Multiple Endocrine Neoplasia Type 2A families

1 reference

12 December 2020

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

12 December 2020

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

1 reference

12 December 2020

Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2

1 reference

12 December 2020

Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations

1 reference

12 December 2020

A novel germline point mutation, c.2304 G-->T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma

1 reference

12 December 2020

RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?

1 reference

12 December 2020

Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease

1 reference

12 December 2020

A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma

1 reference

12 December 2020

Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease

1 reference

12 December 2020

Frequent association between MEN 2A and cutaneous lichen amyloidosis

1 reference

12 December 2020

Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma

1 reference

12 December 2020

Duplication of 9 base pairs in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2A

1 reference

12 December 2020

Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A

1 reference

12 December 2020

A new identified germline mutation of the RET proto-oncogene responsible for familial medullary thyroid carcinoma in co-existence with a hyperfunctioning autonomous nodule

1 reference

12 December 2020

Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.

1 reference

12 December 2020

Editorial: biochemical diagnosis of pheochromocytoma--is it time to switch to plasma-free metanephrines?

1 reference

12 December 2020

A Cys634Gly substitution of the RET proto-oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis

1 reference

12 December 2020

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma

1 reference

12 December 2020

Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II

1 reference

12 December 2020

RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome

1 reference

12 December 2020

Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.

1 reference

12 December 2020

The pressure rises: update on the genetics of phaeochromocytoma

1 reference

12 December 2020

Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.

1 reference

12 December 2020

A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A

1 reference

12 December 2020

Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation

1 reference

12 December 2020

Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine

1 reference

12 December 2020

Presurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing

1 reference

12 December 2020

RET proto-oncogene mutations in French MEN 2A and FMTC families

1 reference

12 December 2020

Pheochromocytoma in multiple endocrine neoplasia type 2: European study

1 reference

12 December 2020

Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma

1 reference

12 December 2020

Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A

1 reference

12 December 2020

Genetic testing for cancer predisposition

1 reference

12 December 2020

A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene

1 reference

12 December 2020

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

1 reference

12 December 2020

Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis

1 reference

12 December 2020

A RET double mutation in the germline of a kindred with FMTC.

1 reference

12 December 2020

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems

1 reference

12 December 2020

Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience.

1 reference

12 December 2020

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

1 reference

12 December 2020

Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties

1 reference

12 December 2020

Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma

1 reference

12 December 2020

Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.

1 reference

12 December 2020

Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET.

1 reference

12 December 2020

Clinical experience over 48 years with pheochromocytoma

1 reference

12 December 2020

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B

1 reference

12 December 2020

Acceptable age for prophylactic surgery in children with multiple endocrine neoplasia type 2a.

1 reference

12 December 2020

Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course

1 reference

12 December 2020

Surgical treatment of medullary thyroid carcinoma

1 reference

12 December 2020

Hirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation

1 reference

12 December 2020

Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B

1 reference

12 December 2020

Novel point mutation in exon 10 of the RET proto-oncogene in a family with medullary thyroid carcinoma.

1 reference

12 December 2020

Lessons Learned from the Management of a Rare Genetic Cancer

1 reference

12 December 2020

Clinical and genetic aspects of phaeochromocytoma

1 reference

12 December 2020

RET mutations in exons 13 and 14 of FMTC patients

1 reference

12 December 2020

How many pathways to pheochromocytoma?

1 reference

12 December 2020

A duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A

1 reference

12 December 2020

Occurrence of pheochromocytoma in a MEN2A family with codon 609 mutation of the RET proto-oncogene

1 reference

12 December 2020

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

1 reference

12 December 2020

Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease

1 reference

12 December 2020

Multiple endocrine neoplasia 2A syndrome: Surgical management

1 reference

12 December 2020

Effects of slow-release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma

1 reference

12 December 2020

Management of malignant phaeochromocytoma: a retrospective review of the use of MIBG and chemotherapy in the West Midlands

1 reference

12 December 2020

Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804.

1 reference

12 December 2020

Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..

1 reference

12 December 2020

Imaging vs biochemical testing for pheochromocytoma

1 reference

12 December 2020

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

1 reference

12 December 2020

Germ-line mutations in nonsyndromic pheochromocytoma

1 reference

12 December 2020

A rare variant, I852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years.

1 reference

12 December 2020

Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients

1 reference

12 December 2020

Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".

1 reference

12 December 2020

Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC

1 reference

12 December 2020

A Rapid Screening Method for the Detection of Mutations in the RET Proto-oncogene in Multiple Endocrine Neoplasia Type 2A and Familial Medullary Thyroid Carcinoma Families

1 reference

12 December 2020

Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma

1 reference

12 December 2020

A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC

1 reference

12 December 2020

A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10

1 reference

12 December 2020

Early Malignant Progression of Hereditary Medullary Thyroid Cancer

1 reference

12 December 2020

Gastrointestinal manifestations of multiple endocrine neoplasia type 2.

1 reference

12 December 2020

Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway.

1 reference

12 December 2020

Adrenal-sparing surgery for phaeochromocytoma

1 reference

12 December 2020

RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease.

1 reference

12 December 2020

A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma

1 reference

12 December 2020

Multiple endocrine neoplasia type 2: clinical aspects

1 reference

12 December 2020

Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas

1 reference

12 December 2020

Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations

1 reference

12 December 2020

Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group

1 reference

12 December 2020

Familial Medullary Thyroid Carcinoma with Noncysteine RET Mutations: Phenotype-Genotype Relationship in a Large Series of Patients

1 reference

12 December 2020

10.1007/S10689-005-0656-Y

Identifiers

DOI

1 reference

PubMed ID

15883707

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

15883707